Aim: To compare metabolic effects and oxidative stress in pregnant and non-pregnant women after 12 h of fasting. Methods: Twenty-six healthy women with uncomplicated singleton pregnancies between the 24 th and 28 th gestational week were recruited. After an overnight fast, venous blood samples and urine samples were tested for metabolic parameters characteristic for starvation, cortisol and oxidative stress products. Healthy non-pregnant women matched by age, body mass index and length of fasting comprised the control group. Results: The metabolic parameters b-hydroxybutyrate and free fatty acids in blood and ketones in urine showed no differences in pregnant and non-pregnant women. However, the oxidative stress parameters, 8,12-iso-iPF 2a -VI, isoprostanes and malondialdehyde were significantly higher in pregnant subjects, as was cortisol. Conclusion: Healthy pregnant women are exposed to oxidative stress and activation of the hypothalamo-pituitary-adrenal axis, but not to metabolic changes resembling starvation during short fasting periods in comparison to non-pregnant healthy women.
Introduction
Normal pregnancy is associated with a systemic inflammatory response. Acute phase reactants and inflammatory leukocytes are elevated, and both endothelial cells and thrombocytes are activated. Some of the metabolic changes during normal pregnancy have similarities with the metabolic syndrome which includes hyperlipidemia, insulin resistance and the activation of the clotting system w12, 17x. Both systemic inflammation and the transient change into the metabolic syndrome in pregnancy were considered to be potential risk factors for both mother and fetus w19x. This view is supported by two important studies, the Framingham Heart Study and the National Health and Nutrition Examination Survey National Epidemiologic Follow-up Study (NHEFS) w9x, where the rates of coronary heart disease were higher among multigravid women than among women who had never been pregnant.
Systemic inflammation is believed to be a physiological response towards ''danger signals'' within the organism. One possible explanation for inflammation in normal pregnancy is an increased level of oxidative stress. Oxidative stress is defined as an imbalance between free radical damage and antioxidant protection, caused by the presence of free radicals or radical-generating agents in concentrations that overwhelm natural radical-blocking or -scavenging mechanisms. Oxidative stress induces oxidative damage to biological substances such as lipids, DNA and proteins w3x and may be responsible for adverse changes in the unborn baby and thereby for effects of fetal programming and -in the long-term -for atherosclerosis and cardiovascular disease in the mother. Cardiovascular health can also be influenced by poor or unbalanced nutrition, increased urinary nitrogen excretion, increased plasma and urinary ketones and raised plasma levels of free fatty acids, the latter acting as a pro-oxidant substance. It is unclear whether the adverse effect of pregnancy (at least multiparity) on maternal cardiovascular health is the result of oxidative stress, activation of the HPA (hypothalamo-pituitary-adrenal)-axis, metabolic changes resembling starvation (catabolism) or a mixture thereof. We, therefore, examined whether pregnant women matched by age, body mass index (BMI) and duration of fasting are exposed to oxidative stress, activation of the HPA-axis and/or catabolic metabolism in comparison to non-pregnant women.
Materials and methods
A total of 27 healthy volunteers with uncomplicated singleton pregnancies between the 24 th and 28 th gestational week were recruited from the Department of Obstetrics at the University Hospital of Zurich in association with a routine fasting glucose 290 Schraag et al., Short-term starvation in pregnancy Article in press -uncorrected proof control. The same number of healthy non-pregnant women matched by age group, BMI and length of fasting were recruited as a controls from the employees of the University Hospital. The non-pregnant controls were advised to fast for exactly the same time as their pregnant match. One pregnant woman was excluded from the study because gestational diabetes was diagnosed. Hence a total of 26 women were in each group, which allows a statistically significant interpretation of the results. Both the pregnant and the non-pregnant participants of the study were in good general health and had no disease or problems with their carbohydrate metabolism. Aside from standard prenatal vitamins or iron supplements they were not taking any medication. Each of the pregnant women gave birth to a healthy child. All volunteers gave written informed consent to participate in this study. The participation to this study was not financially rewarded.
To calculate the BMI of the pregnant women we used the pregravid weight. For randomization, we divided the women into four age- (16-20, 21-30, 31-40 and 41-45 years) and BMI groups (-20 underweight, 20-24.9 normal, 25-29.9 overweight, 30-39.9 obese) . Age was calculated in completed years, whereas gestational age was measured accurate to a day. Gestational age was determined by the last menstrual period and corrected with early ultrasound, if necessary. Further details are given in Table 1 .
Following an overnight fast, 25 mL of venous blood was taken and tested for free fatty acids (FFA), b-hydroxybutyrate, cortisol/ insulin-ratio and malondialdehyde. In addition, the subjects gave a morning urine sample which was used to measure ketones, creatinine, isoprostanes and 8,12-iso-iPF 2a -VI. The same blood and urine samples were taken from non-pregnant controls at the same time in the morning after fasting overnight and skipping breakfast.
The study protocol was approved by the local Ethical Committee of the University of Zurich/Switzerland.
As oxidative stress markers we used malondialdehyde (MDA) in blood serum and 8,12-iso-iPF 2a -VI and isoprostanes in urine corrected for creatinine. Markers for the metabolic status were cortisol/insulin ratio, serum-glucose, free fatty acids (FFA) and b-hydroxybutyrate. The blood samples were processed and frozen at -208C just after blood withdrawal and the urine samples just after collection, to avoid auto-oxidation or other processes that may have changed the concentration of the measured parameters.
All markers except MDA, isoprostanes and 8,12-iso-iPF 2a -VI were measured at the Institute for Clinical Chemistry, University Hospital in Zurich.
Basal cortisol was determined in heparinized plasma by an electrochemiluminescence assay. b-hydroxybutyrate was measured by an enzymatic rate method with the use of b-hydroxybutyrate dehydrogenase. FFA in serum was determined by an enzymatic colorimetric-test and insulin with chemiluminescence assays. For the analysis of MDA, EDTA blood was separated by centrifugation at 48C immediately after blood-withdrawal. The separated plasma samples were frozen and stored at -208C until analysis in the research laboratory of the Department of Obstetrics of the Zurich University Hospital using the Lipid Peroxidation Assay Kit from Calbiochem (Cat No 437634, Merck Biosciences, Darmstadt, Germany). The principle of this colorimetric assay is the reaction of a chromogenic reagent with MDA at 458C. One molecule of MDA condensates with two molecules of the reagent to yield a stable chromophore with a maximal absorbance at 586 nm. Isoprostanes were analyzed in urine samples that were frozen at -808C in the Department of Pediatrics at PhilippsUniversity Marburg, Germany. The samples were processed as follows: Urine (100 mL) was diluted with 200 mL water and tetradeuterated w 2 H 4 x-PGF 2a (1 ng in 10 mL ethyl acetate) was added.
After acidification with formic acid to pH 2.5, the prostanoids were extracted twice with 1 mL ethyl acetate-hexane (70:30, v/v). After evaporation of the solvent, acetone (80 mL), N,N-diisopropylethylamine (7 mL) and pentafluorobenzyl bromide (6 mL) were added. The mixture was allowed to react at 408C for 25 min. The dry sample was purified by thin layer chromatography (TLC, developing solvent: ethyl acetate-hexane 90:10, v/v). A broad zone (R F 0.03-0.39) was eluted with the TLC developing solvent (1 mL) and water (50 mL) was added. After centrifugation, the ethyl acetate phase was withdrawn, the solvent was evaporated and the prostanoids derived with BSTFA: N,Obis(trimethylsilyl)trifluoro acetamide (10 mL; 408C, 1 h). A 1 mL aliquot of this solution was injected.
For the analysis of 8,12-iso-iPF 2a -VI urine (1 mL) and w 2 H 11 x-8,12-iso-iPF 2a -VI (1 ng) were acidified with formic acid to pH 2.5 and the prostanoids were extracted twice with 3 mL of ethyl acetate-hexane (70:30, v/v). After evaporation of the solvent, acetonitrile (80 mL), pentafluorobenzyl bromide (7 mL) and N,Ndiisopropylethylamine (25 mL) were added. The mixture was allowed to react at 408C for 25 min. The dry sample was purified by TLC (developing solvent: ethyl acetate-methanol 100:3, v/v). The zone with an R F 0.2-0.33 was eluted with TLC ethylacetate (800 mL) and water (50 mL) was added. Further sample preparation was as described for the isoprostanes.
The concentration of each parameter in the prepared urine samples was determined using gas chromatography/tandem mass spectrometry (GC/MS/MS). A Finnigan MAT TSQ700 tan- 
Results
The groups were similar regarding fasting time, BMI, and age (Table 1 ). The concentrations of circulating oxidative and metabolic parameters are summarized in Table 2 . The women's individual BMI did not correlate with the measured concentration of oxidative stress products. Regarding cortisol, we found a slight, but not a significant increase with greater BMI in pregnant women. No significant correlation was observed for non-pregnant subjects.
Metabolic parameters: Serum-insulin tended to be higher in pregnant women, but the difference did not reach significance ( Table 2 ). All of the metabolic parameters (serum-glucose, free fatty acids (FFA), b-hydroxybutyrate and the cortisol/insulin-ratio) were not significant (Table 2) .
HPA-axis:
We observed a significant elevation of cortisol in pregnant subjects (Ps0.0002) compared to nonpregnant subjects (Figure 1) .
Oxidative stress parameters: The tested oxidative stress parameters, namely isoprostanes (P-0.0001), 8,12-iso-iPF 2a -VI (Ps0.0008) (Figure 2) , and malondialdehyde (P-0.0001) (Figure 3) , were significantly elevated in pregnant women.
Comment
We could show that after a short starvation, all of our tested parameters of oxidative stress as well as serum cortisol levels were significantly elevated in pregnant women in the late second trimester in comparison to healthy non-pregnant controls. Metabolic parameters indicative of catabolism, however, were not altered.
The level of oxidative stress may vary considerably throughout day and night and depends on the interval since the last food intake. This might be the reason for the conflicting results in the literature regarding the occurrence of oxidative stress in normal pregnancy and in preeclampsia w4, 7, 15x. Consequently, the metabolic parameters of catabolism and plasma levels of cortisol vary significantly if they are not measured under standard conditions. The measurements in our study were conducted in a healthy pregnant population matched with the non-pregnant controls for BMI, age and period of fasting. Moreover, serum malondialdehyde and 8,12-isoiPF 2a -VI and isoprostanes in urine corrected for creatinine are the most reliable markers for oxidative stress w2, 15, 16x. We measured oxidative stress, cortisol and the metabolic parameters the morning after an overnight fast, because this interval allows for standardized measurements and represents a common metabolic situation occurring in many pregnant women who decide to skip breakfast due to personal preference, work overload, or for laboratory testing. Therefore, we believe that our results truly reflect increased oxidative stress and an activation of the HPA-axis in pregnant women in comparison to non-pregnant women under physiological conditions.
It is well known that both oxidative stress and increased plasma cortisol levels are risk factors for atherosclerosis and cardiovascular disease w22x. Interestingly, women having six or more pregnancies show a consistently increased risk of coronary heart and cardiovascular disease w9x. However, the same tendency was observed with a lower number of pregnancies w9x. Oxidative stress in pregnancy, in combination with an activation of the HPA-axis, may induce micro-damage to maternal arteries and, therefore, might serve as a possible link between multigravidity and adverse maternal long term outcome. However, the mother may not be the only one affected by oxidative stress and an activated HPA axis in pregnancy, because it was hypothesized that unfavorable influences during pregnancy can have a long lasting impact on the unborn baby (Barker9s hypothesis of ''Fetal Programming'' w1, 10x) . The exact mechanisms responsible for fetal programming are unknown. It has been proven that women with poor nutrition and a stressful pregnancy have a greater risk of bearing an underweight baby that could be affected by the aforementioned diseases w5, 13x. Epidemiological studies on the effect of severe maternal long term starvation during the Dutch famine in World War II showed that this is associated with decreased glucose tolerance and altered endothelial function in the offspring, especially when they became obese w13x. However, this association could only be shown in the Dutch famine study, but not in the Leningrad siege study w21x.
There is overwhelming evidence that suboptimal conditions experienced during intrauterine life could affect critical fetal systems. Elevated cortisol levels and oxidative stress may be the agents of intrauterine mal-programming of endocrine and circulatory regulatory systems with the consequence of an increased susceptibility for diseases in later life w8, 20x. Oxidative stress in pregnancy may, therefore, affect the health of mother and fetus alike.
Important substances for the diagnosis of oxidative stress are the isoprostanes. They are prostaglandin F 2 -like compounds that are generated in vivo in humans by non-enzymatic free radical-induced peroxidation of arachidonic acid and show high stability w22x. Isoprostanes have been shown to be elevated in a number of disorders that are possibly associated with oxidative stress w16x.
One of the major compounds of this group, 8,12-isoiPF 2a -VI, is a chemically stable, free-radical catalyzed isoprostane that reflects lipid peroxidation. After free-radical attack, it is cleaved from the plasma membrane into the blood and excreted in the urine. This substance has particular importance as an indicator of oxidative stress in vivo.
Interestingly, in our study, metabolic parameters indicative of catabolism were not elevated in the late second trimester in comparison to non-pregnant controls after a mean fasting time of 12 h. Free fatty acids induce oxidative stress and, therefore, catabolism is thought to be a cardiovascular risk factor. Catabolism in our study is unlikely to be the reason for the elevated oxidative stress parameters. Metzger et al. w6x described the socalled ''accelerated starvation'' after a fasting period of 18 h in the third trimester of pregnancy. After 12 h of fasting, the results resemble ours in so far that they could not show catabolic changes in pregnant women. As far as carbohydrate metabolism is concerned, other studies found similar results to those found by Metzger et al. with catabolism and fat mobilization after the first 12 h of starvation w11, 14, 18x. Because of ethical reasons, prolongation of the fasting time was not contrivable in our study.
To the best of our knowledge, this is the first study to simultaneously examine metabolic parameters characteristic for catabolism, plasma basal cortisol and oxidative stress under standardized conditions in pregnancy. Each of the three parameters serves as a risk factor for cardiovascular disease. We were able to show that oxidative stress parameters and cortisol levels are elevated during normal pregnancy after ''skipping breakfast'' in comparison to non-pregnant controls. This elevation is not accompanied by metabolic signs of starvation. We hypothesize that the combination of oxidative stress and an activation of the HPA-axis is the link between the long term adverse effects of pregnancy (at least in multiparity) for cardiovascular diseases and (if further increased) might induce an adverse intrauterine environment that can have unfavorable and long-lasting effects on the fetus. Our study, therefore, serves as a theoretical basis that antioxidants might be useful to prevent long term adverse effects of multiparity on maternal health.
